The Recall Desk
SevereFDA (Drugs)·D-0743-2020·Announced 2020-01-22

Assurance Infusion Recalls Hydromorphone Syringes Due to Sterility Concerns

Assurance Infusion is recalling specific lots of Hydromorphone 2mg/mL injection syringes because of a lack of sterility assurance.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or health risks.

Plain-English summary

Assurance Infusion is recalling four syringes of Hydromorphone 2mg/mL injection. The recall is due to a lack of sterility assurance in the product.

The affected product is distributed nationwide within the United States. Specific lot numbers and expiration dates are listed in the recall documentation.

Consumers and healthcare providers should stop using the recalled product and contact Assurance Infusion for further instructions.

The recalled product

Product
HYDROMORPHONE 2MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
Manufacturer
Assurance Infusion
Category
Drug — Injection
Hazard
Affected units
4

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lots: 12112019@1 Exp. 12/20/2019
  • 12112019@6 Exp. 12/20/2019
  • 12162019@23 Exp. 12/25/2019
  • 12172019@7 Exp. 12/26/2019

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 118 products in this recall →

Related recalls

Same manufacturer · Assurance Infusion

See all →

Same hazard · sterility

See all →